Legal Representation
Attorney
Anne E. Naffziger
USPTO Deadlines
Application History
36 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 1, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
May 31, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Nov 4, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 3, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Nov 3, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Oct 23, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 23, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Apr 17, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 15, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 15, 2020 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Apr 15, 2020 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Oct 25, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 23, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 23, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Oct 23, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Apr 20, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 18, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 18, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Apr 18, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Oct 26, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 24, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 24, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Oct 24, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 24, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 27, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 27, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 7, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 22, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 15, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 12, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 12, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jan 12, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 12, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 12, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Oct 11, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 7, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
biological preparations for the treatment of cancer and inflammation
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized wording "ANAPTYSBIO V" wherein the wording "ANAPTYS" is in black, "BIO" is in blue, and the letter "V" is formed by two black lines and a blue line. The color white represents transparent background and is not claimed as a feature of the mark.
Color Claim
The color(s) black and blue is/are claimed as a feature of the mark.
Classification
International Classes
001
005